Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Tormey

Showing results (41-50 of 137) with videos related to

Pageof 14
Sort By:
Cancer Research|June 1, 1985
Phase I clinical study with pharmacokinetic analysis of 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC 286193) administered as a five-day infusionD L Trump, K D Tutsch, J M Koeller, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Long-term survival of patients treated with combination chemotherapy for metastatic breast cancerG Falkson, D C Tormey, P Carey, et al.
Cancer|June 1, 1977
Biological markers in breast carcinoma. III. Clinical correlations with carcinoembryonic antigenD C Tormey, T P Waalkes, J J Snyder, et al.
American Journal of Clinical Oncology|June 1, 1989
Combined modality treatment of local regionally advanced breast cancer patients. 5 to 10 year follow-upC L Loprinzi, P W Rasmussen, D C Tormey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1993
Tumor necrosis is a prognostic predictor for early recurrence and death in lymph node-positive breast cancer: a 10-year follow-up study of 728 Eastern Cooperative Oncology Group patientsK W Gilchrist, R Gray, B Fowble, et al.
Cancer|February 1, 1996
A randomized trial of megestrol acetate with or without premarin in the treatment of potentially responsive metastatic breast cancer. A Study of the Eastern Cooperative Oncology Group (E2185)C D Cobau, K Declercq, D Neuberg, et al.
Archives of Otolaryngology (Chicago, Ill. : 1960)|August 1, 1978
Synovial sarcoma of the neck associated with previous head and neck radiation therapyN E Mischler, T Chuprevich, D C Tormey, et al.
Cancer Treatment Reports|November 1, 1976
Evaluation of an intermittent schedule of dibromodulcitol in breast cancerD C Tormey, G Falkson, E Perlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1988
Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapyB Fowble, R Gray, K Gilchrist, et al.
Cancer Treatment Reports|July 1, 1985
Mitomycin and tamoxifen versus mitolactol, doxorubicin, and tamoxifen in patients with previously treated breast cancerG Falkson, R S Gelman, D C Tormey, et al.
Pageof 14

Showing results (41-50 of 137) with videos related to

Sort By:
Pageof 14
Cancer Research|June 1, 1985
Phase I clinical study with pharmacokinetic analysis of 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC 286193) administered as a five-day infusionD L Trump, K D Tutsch, J M Koeller, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Long-term survival of patients treated with combination chemotherapy for metastatic breast cancerG Falkson, D C Tormey, P Carey, et al.
Cancer|June 1, 1977
Biological markers in breast carcinoma. III. Clinical correlations with carcinoembryonic antigenD C Tormey, T P Waalkes, J J Snyder, et al.
American Journal of Clinical Oncology|June 1, 1989
Combined modality treatment of local regionally advanced breast cancer patients. 5 to 10 year follow-upC L Loprinzi, P W Rasmussen, D C Tormey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1993
Tumor necrosis is a prognostic predictor for early recurrence and death in lymph node-positive breast cancer: a 10-year follow-up study of 728 Eastern Cooperative Oncology Group patientsK W Gilchrist, R Gray, B Fowble, et al.
Cancer|February 1, 1996
A randomized trial of megestrol acetate with or without premarin in the treatment of potentially responsive metastatic breast cancer. A Study of the Eastern Cooperative Oncology Group (E2185)C D Cobau, K Declercq, D Neuberg, et al.
Archives of Otolaryngology (Chicago, Ill. : 1960)|August 1, 1978
Synovial sarcoma of the neck associated with previous head and neck radiation therapyN E Mischler, T Chuprevich, D C Tormey, et al.
Cancer Treatment Reports|November 1, 1976
Evaluation of an intermittent schedule of dibromodulcitol in breast cancerD C Tormey, G Falkson, E Perlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1988
Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapyB Fowble, R Gray, K Gilchrist, et al.
Cancer Treatment Reports|July 1, 1985
Mitomycin and tamoxifen versus mitolactol, doxorubicin, and tamoxifen in patients with previously treated breast cancerG Falkson, R S Gelman, D C Tormey, et al.
Pageof 14